Navigation Links
Oramed Pharmaceuticals Chosen to Present Results of GLP-1 Analog Enteral Administration Study at the Diabetes Technology Society's Eighth Annual Meeting (November 13-15, 2008; Bethesda, Maryland)
Date:11/4/2008

injection. Oramed is seeking to revolutionize the treatment of diabetes through its patented flagship product, an orally ingestible insulin capsule currently in phase 2 clinical trials. Established in 2006, Oramed's technology is based on over 25 years of research by top research scientists at Jerusalem's Hadassah Medical Center. The Company's corporate and R&D headquarters are based in Jerusalem.

For more information, please visit http://www.oramed.com

Forward-looking statements

Some of the statements contained in this press release are forward-looking statements which involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward looking statements, including the risks and uncertainties related to the progress, timing, cost, and results of clinical trials and product development programs; difficulties or delays in obtaining regulatory approval for our product candidates; competition from other pharmaceutical or biotechnology companies; and the company's ability to obtain additional funding required to conduct its research, development and commercialization activities. Please refer to the company's filings with the Securities and Exchange Commission for a comprehensive list of risk factors that could cause actual results, performance or achievements of the company to differ materially from those expressed or implied in such forward looking statements. The company undertakes no obligation to update or revise any forward-looking statements.

Company and Investor Relation Contacts:

Oramed Pharmaceuticals

Eric Rosenberg

Cell: +972-54-566-7713

Office: +972-2-566-0001

Email: eric@oramed.com

Media Con
'/>"/>

SOURCE Oramed Pharmaceticals
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Oramed Pharmaceuticals Launches Phase 1A Trials of its Insulin Suppository
2. /K I L L K I L L K I L L -- Oramed Pharmaceuticals Inc./
3. Oramed Pharmaceuticals Commences Phase 2A Trials of its Oral Insulin Capsule on Type 1 Diabetics
4. Oramed Pharmaceuticals Launches GLP1-Analog Program, Based on its Proprietary Drug Delivery Platform
5. Oramed Pharmaceuticals Chosen to Present Oral Insulin Trial Results at EASD Conference (September 7-11, Rome)
6. Oramed Pharmaceuticals Announces Successful Phase 2A Clinical Trial of its Oral Insulin Capsule
7. Oramed Pharmaceuticals to Hold Conference Call on August 6 to Present Results of Phase 2A Oral Insulin Capsule Clinical Trials
8. Mpex Pharmaceuticals Announces Initiation of a Phase 2 Clinical Trial of Aerosol MP-376 in COPD
9. Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers
10. Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Next Generation Oxazolidinone at 2008 ICAAC/IDSA Joint Meeting
11. Sequoia Pharmaceuticals Presents In Vitro and First-in-Human Data Supporting Further Development of SPI-256, a Novel Investigational Protease Inhibitor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... Colo. , Nov. 25, 2014 /PRNewswire/ ... ) today announced that its Chief Executive ... at the following upcoming conferences.  The public ... through webcasts on the Array BioPharma website:  ... December 3, 2014Time:1:30 p.m.  Eastern Time Location: ...
(Date:11/26/2014)... Nov. 25, 2014 Immune Pharmaceuticals Inc. ... stage biopharmaceutical company that engages in the development ... of inflammatory diseases and cancer, today announced the ... of 3,450,000 units, with each unit consisting of ... value $0.0001 per share, and one warrant to ...
(Date:11/24/2014)...  CryoLife, Inc. (NYSE: CRY ), a leading ... vascular surgery, announced today that it will participate in the ... Wednesday, December 3, 2014 at The New York Palace Hotel ... A live webcast of the Company,s presentation is scheduled to ... of the company by Pat Mackin , President and ...
Breaking Medicine Technology:Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 2Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 3Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 4Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 5CryoLife to Present at 26th Annual Piper Jaffray Healthcare Conference 2CryoLife to Present at 26th Annual Piper Jaffray Healthcare Conference 3
(Date:11/26/2014)... Dr. Parsa Mohebi is giving prospective ... With Parsa Mohebi Hair Restoration’s new winter special, patients ... FUE procedure, making it that much easier to get ... Unit Extraction”—is an advanced variety of hair restoration surgery ... Transplantation (FUT). FUE, unlike FUT, does not leave a ...
(Date:11/26/2014)... 27, 2014 Recently, Locks-Magnetic.com, a Chinese ... collection of magnetic locks on the Internet. It also ... until December. , As a leading company in ... for worldwide customers to buy high quality locks. It ... it provides locks that are not only useful but ...
(Date:11/26/2014)... (PRWEB) November 27, 2014 Boxing Day ... and tradesmen would receive gifts, known as a "Christmas ... Wikipedia ) , With the coming of Boxing Day, ... Tbdress.com is smart before every business opportunity, and it ... ”, offering a site-wide promotion for its global customers. ...
(Date:11/26/2014)... (PRWEB) November 26, 2014 Pharmaceutical ... humidity, and pressure levels during manufacturing and research ... and air conditioning) systems play a key role. ... microorganisms or bio-contaminants, while humidity can affect the ... The use of HVAC systems helps to address ...
(Date:11/26/2014)... Dallas, Texas (PRWEB) November 26, 2014 ... surgeon and Distinguished Teaching Professor in the ... Center, recently discussed facial fat compartments, fat grafting, ... Surgery, The Meeting," an annual conference held by ... importance and intricacies of this underlying facial structure ...
Breaking Medicine News(10 mins):Health News:FUE Special at Parsa Mohebi Hair Restoration This Holiday Season 2Health News:Fresh Products Launched by Famous Company Lock-Magnetic.com 2Health News:Tbdress.com: Best Boxing Day Sales For Ladies Worldwide 2Health News:Cleanroom Technology Market to Hit $3,761.9 Million by 2019 - New Research Report by MarketsandMarkets 2Health News:Cleanroom Technology Market to Hit $3,761.9 Million by 2019 - New Research Report by MarketsandMarkets 3Health News:Cleanroom Technology Market to Hit $3,761.9 Million by 2019 - New Research Report by MarketsandMarkets 4Health News:Cleanroom Technology Market to Hit $3,761.9 Million by 2019 - New Research Report by MarketsandMarkets 5Health News:Dr. Rod J. Rohrich Discusses Facelifts at ASPS Annual Assembly 2Health News:Dr. Rod J. Rohrich Discusses Facelifts at ASPS Annual Assembly 3
... Socit de Pathologie Exotique , launched shortly after the ... and English as well as meeting reports. Today, ... and is recognized for its impressive collection of tropical ... students, the Bulletin appears five times per year and ...
... suggests that exempting bars from community smoking bans makes ... and that even the most comprehensive clean indoor air ... jobs. , Researchers hope the findings, based on a ... municipalities and states considering the economic and health issues ...
... Equality,s Judicial Victory Leads to Legislative ... Guardianship CHICAGO, May 18 Today, the Illinois ... adults with disabilities under guardianship without due process. ... disabilities under guardianship has been preserved. The bill, ...
... into State-of-the-Art Neonatal Intensive Care Unit WASHINGTON, May ... home at Children,s National Medical Center. The new, ... when the babies were transported from the hospital,s ... http://www.newscom.com/cgi-bin/prnh/20090518/DC18562 )"This NICU was ...
... Now Available for Use in Clinical Trials and Population Health ... vital to health and well-being as a good night,s sleep. ... the National Sleep Foundation -- suffer from chronic sleep problems ... showing correlations between poor or insufficient sleep and disease. Now ...
... resource from ACTS Retirement-Life Communities helps consumers ask the right questions ... ... West Point, PA (Vocus) May 18, 2009 -- Preparing ... many factors to consider, including present and future needs, personal preferences, ...
Cached Medicine News:Health News:Study: Smoking bans do not cause job losses in bars and restaurants 2Health News:Study: Smoking bans do not cause job losses in bars and restaurants 3Health News:Study: Smoking bans do not cause job losses in bars and restaurants 4Health News:Passage of Illinois House Bill 2290 Adds Crucial Due Process Protection Governing Sterilization of Adults With Disabilities 2Health News:Passage of Illinois House Bill 2290 Adds Crucial Due Process Protection Governing Sterilization of Adults With Disabilities 3Health News:The Most Fragile Babies in the Nation's Capital Have a New Home 2Health News:QualityMetric Offers Way to Measure the Impact of Sleep Problems on Individuals and Groups 2Health News:7 Tips for Choosing a Retirement Community 2Health News:7 Tips for Choosing a Retirement Community 3
Maltzman-Fenzl lens manipulator, V shaped tip, straight. Also available in titanium....
0.3 mm diameter hemi-ball tip....
Vaulted shank with guard....
... individually adjusted for perfect focus where it's ... paper. This, along with Keeler's wide angle ... whatever the patient's pupil size, you will ... view. Lithium-ion technology provides a longer life ...
Medicine Products: